Insider Transactions last 24 months for Aclaris Therapeutics, Inc.  -  NSDQ: ACRS

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Balthaser KevinChief Financial Officer03/01/2026DFDirectCOM677$2.87$1,942.99187,453
Balthaser KevinChief Financial Officer03/01/2026AMDirectCOM2,375$0.00$0.00188,130
Walker NealCEO02/03/2026DFDirectCOM18,611$3.47$64,580.171,543,886
Walker NealCEO02/03/2026AMDirectCOM63,475$0.00$0.001,562,497
Loerop JamesChief Business Officer02/03/2026DFDirectCOM5,937$3.47$20,601.39192,260
Loerop JamesChief Business Officer02/03/2026AMDirectCOM20,875$0.00$0.00198,197
Balthaser KevinChief Financial Officer02/03/2026DFDirectCOM6,449$3.47$22,378.03185,755
Balthaser KevinChief Financial Officer02/03/2026AMDirectCOM22,025$0.00$0.00192,204
Davis Hugh M.President and COO02/03/2026AMDirectCOM18,675$0.00$0.0045,425
Balthaser KevinChief Financial Officer02/01/2026DFDirectCOM4,984$3.51$17,493.84170,179
Balthaser KevinChief Financial Officer02/01/2026AMDirectCOM14,750$0.00$0.00175,163
Walker NealCEO01/02/2026DFDirectCOM9,952$2.88$28,661.761,499,022
Walker NealCEO01/02/2026AMDirectCOM29,150$0.00$0.001,508,974
Loerop JamesChief Business Officer01/02/2026DFDirectCOM6,171$2.88$17,772.48155,041
Loerop JamesChief Business Officer01/02/2026AMDirectCOM18,150$0.00$0.00161,212
Balthaser KevinChief Financial Officer01/02/2026DFDirectCOM4,461$2.88$12,847.68160,413
Balthaser KevinChief Financial Officer01/02/2026AMDirectCOM13,200$0.00$0.00164,874
Balthaser KevinChief Financial Officer01/01/2026DFDirectCOM2,250$3.01$6,772.50151,674
Balthaser KevinChief Financial Officer01/01/2026AMDirectCOM7,500$0.00$0.00153,924
Loerop JamesChief Business Officer12/31/2025DFDirectCOM33,994$3.01$102,321.94143,062
Loerop JamesChief Business Officer12/31/2025AMDirectCOM73,750$0.00$0.00177,056
Balthaser KevinChief Financial Officer12/31/2025DFDirectCOM19,934$3.01$60,001.34146,424
Balthaser KevinChief Financial Officer12/31/2025AMDirectCOM73,750$0.00$0.00166,358
Davis Hugh M.President and COO12/02/2025AMDirectCOM26,750$0.00$0.0026,750
Molineaux Christopher P.Director06/06/2025AMDirectCOM4,793$0.00$0.0057,956
1   2  3  4  5  Next Last  You are at page 1 of 5 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel